Company Filing History:
Years Active: 2016-2020
Title: Maher Albitar: Innovator in Hematologic Diagnostics
Introduction
Maher Albitar is a prominent inventor based in Valley Center, California, known for his significant contributions to the field of hematologic diagnostics. With a total of seven patents to his name, he has made remarkable advancements in the diagnosis and management of blood-related disorders.
Latest Patents
Among his latest patents is a method for deep sequencing of peripheral blood plasma DNA, which serves as a reliable test for confirming the diagnosis of myelodysplastic syndrome. This innovative approach includes methods for treating, managing, diagnosing, and monitoring myelodysplastic syndrome and other hematologic malignancies. Another notable patent focuses on determining tumor load and biallelic mutation in patients with CALR mutation using peripheral blood plasma. This patent provides compositions and fragment length analysis methods for detecting CALR mutations and assessing tumor load in patients with myeloproliferative neoplasms.
Career Highlights
Throughout his career, Maher Albitar has worked with esteemed organizations such as NeoGenomics Laboratories, Inc. and Health Discovery Corporation. His expertise in the field has led to significant advancements in diagnostic methodologies, particularly in the realm of cancer diagnostics.
Collaborations
One of his notable collaborators is Hong J Zhang, with whom he has worked on various projects aimed at enhancing diagnostic accuracy in hematology.
Conclusion
Maher Albitar's innovative work in hematologic diagnostics has paved the way for improved patient outcomes and has established him as a key figure in the field. His contributions continue to influence the landscape of medical diagnostics, showcasing the importance of innovation in healthcare.